Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term visual acuity outcomes following cataract surgery in eyes with ocular inflammatory disease.
Gangaputra S, Newcomb C, Armour R, Choi D, Ying GS, Groth S, Begum H, Fitzgerald T, Artornsombudh P, Daniel E, Bhatt N, Foster S, Jabs D, Levy-Clarke G, Nussenblatt R, Rosenbaum JT, Sen HN, Suhler E, Thorne J, Dreger K, Buchanich J, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group. Gangaputra S, et al. Among authors: sen hn. Br J Ophthalmol. 2024 Feb 21;108(3):380-385. doi: 10.1136/bjo-2022-322236. Br J Ophthalmol. 2024. PMID: 36810151
Mycophenolate mofetil for the treatment of scleritis.
Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR. Sen HN, et al. Ophthalmology. 2003 Sep;110(9):1750-5. doi: 10.1016/S0161-6420(03)00570-0. Ophthalmology. 2003. PMID: 13129873 Clinical Trial.
Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration.
Nussenblatt RB, Thompson DJ, Li Z, Chan CC, Peterson JS, Robinson RR, Shames RS, Nagarajan S, Tang MT, Mailman M, Velez G, Roy C, Levy-Clarke GA, Suhler EB, Djalilian A, Sen HN, Al-Khatib S, Ursea R, Srivastava S, Bamji A, Mellow S, Sran P, Waldmann TA, Buggage RR. Nussenblatt RB, et al. Among authors: sen hn. J Autoimmun. 2003 Nov;21(3):283-93. doi: 10.1016/s0896-8411(03)00113-6. J Autoimmun. 2003. PMID: 14599854 Clinical Trial.
Waldenström's macroglobulinemia-associated retinopathy.
Sen HN, Chan CC, Caruso RC, Fariss RN, Nussenblatt RB, Buggage RR. Sen HN, et al. Ophthalmology. 2004 Mar;111(3):535-9. doi: 10.1016/j.ophtha.2003.05.036. Ophthalmology. 2004. PMID: 15019332
Occult primary carcinoma metastatic to the iris.
Sen HN, Chan CC, Nussenblatt RB, Buggage RR. Sen HN, et al. Acta Ophthalmol Scand. 2004 Dec;82(6):746-7. doi: 10.1111/j.1600-0420.2004.00273.x. Acta Ophthalmol Scand. 2004. PMID: 15606475 Free article. No abstract available.
A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease.
Buggage RR, Levy-Clarke G, Sen HN, Ursea R, Srivastava SK, Suhler EB, Altemare C, Velez G, Ragheb J, Chan CC, Nussenblatt RB, Bamji AT, Sran P, Waldmann T, Thompson DJ. Buggage RR, et al. Among authors: sen hn. Ocul Immunol Inflamm. 2007 Mar-Apr;15(2):63-70. doi: 10.1080/09273940701299370. Ocul Immunol Inflamm. 2007. PMID: 17558830 Free PMC article. Clinical Trial.
Infliximab for the treatment of active scleritis.
Sen HN, Sangave A, Hammel K, Levy-Clarke G, Nussenblatt RB. Sen HN, et al. Can J Ophthalmol. 2009 Jun;44(3):e9-e12. doi: 10.3129/i09-061. Can J Ophthalmol. 2009. PMID: 19506593 Free PMC article. Clinical Trial.
209 results